XML 73 R20.htm IDEA: XBRL DOCUMENT v3.24.3

CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)

9 Months Ended

Sep. 30, 2024

Cash and Cash Equivalents [Abstract]

Schedule of Cash, Cash Equivalents and Investments

Our total cash, cash equivalents and investments are summarized below:

			September 30, 2024												December 31, 2023
(in millions)			Cash and cash equivalents			Available-for-sale marketable securities						Total						Cash and cash equivalents			Available-for-sale marketable securities						Total
Cash and cash equivalents			$	251		$	—					$	251					$	287		$	—					$	287
Investments			—			50						50						—			65						65
Restricted cash, cash equivalents and investments:
Payroll funds collected			496			—						496						1,067			—						1,067
Collateral for health benefits claims			42			111						153						31			113						144
Collateral for workers' compensation claims			48			—						48						54			2						56
Trust for our HRIS Users			81			—						81						—			—						—
Other security deposits			2			—						2						2			—						2
Total restricted cash, cash equivalents and investments			669			111						780						1,154			115						1,269
Investments, noncurrent			—			145						145						—			143						143
Restricted cash, cash equivalents and investments, noncurrent
Collateral for workers' compensation claims			28			125						153						25			133						158
Total			$	948		$	431					$	1,379					$	1,466		$	456					$	1,922

X

- References

No definition available.

+ Details

Name:	us-gaap_CashAndCashEquivalentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of cash, cash equivalents, and investments.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration